Drug profile · INN
levoleucovorin
KHAPZORY
levoleucovorin (KHAPZORY) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — levoleucovorin
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
levoleucovorin (KHAPZORY) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN levoleucovorin
Brand KHAPZORY
Mechanism Unknown
Route INTRAVENOUS
Formulation POWDER
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is levoleucovorin?
levoleucovorin (KHAPZORY) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for levoleucovorin?
KHAPZORY is a marketed brand name for levoleucovorin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levoleucovorin?
levoleucovorin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.